Disclaimer: This site aggregates publicly available data from official government sources (FDA, ClinicalTrials.gov, PubMed, SEC EDGAR, NMPA) for general reference only. It does NOT constitute medical advice, diagnosis, treatment recommendations, or investment advice.

Clinical Trial

Selective Pulmonary-artery Intervention to Reduce Acute Right-heart tEnsion-II

NCT: NCT06576427 · COMPLETED

NCT IDNCT06576427
StatusCOMPLETED
Start Date2024-10-15
Completion2026-03-03

Brief Summary

This study is a prospective, single-arm, multicenter study to evaluate the safety and effectiveness of the Vertex Pulmonary Embolectomy System in participants presenting with clinical signs and symptoms of acute pulmonary embolism.

Frequently Asked Questions

What is Selective Pulmonary-artery Intervention to Reduce Acute Right-heart tEnsion-II?

Selective Pulmonary-artery Intervention to Reduce Acute Right-heart tEnsion-II is a clinical trial registered under NCT06576427. Current status: COMPLETED.

What is the status of NCT06576427?

The current status of NCT06576427 (Selective Pulmonary-artery Intervention to Reduce Acute Right-heart tEnsion-II) is: COMPLETED.

When did Selective Pulmonary-artery Intervention to Reduce Acute Right-heart tEnsion-II start?

Selective Pulmonary-artery Intervention to Reduce Acute Right-heart tEnsion-II started on 2024-10-15.

Official Source

View on ClinicalTrials.gov →

Data sourced from ClinicalTrials.gov API. For the most current status, refer to the official record.

↑